Tuya
Tuya Pal, MD
Dr. Pal is a Professor of Medicine at the Vanderbilt University Medical Center, where she is also an Ingram Professor of Cancer Research.
A board-certified practicing clinical cancer geneticist, Dr. Pal’s clinical activities are solely focused on evaluation and management of patients with or at risk for inherited cancer. She is also the Vice Chair of the National Comprehensive Cancer Network Genetics/Familial Guidelines Committee for Breast, Ovarian, Pancreatic, and Prostate Cancers, as well as the Editor-in-Chief for the National Cancer Institute’s Cancer Genetics PDQ Editorial Board.
Dr. Pal’s research has focused on genomics, etiology, outcomes, and care delivery among inherited cancer and/or underrepresented populations, particularly young Black women with breast cancer. She has led multiple efforts focused on alternative models to streamline and scale up care delivery of cancer genetics services across diverse populations and healthcare settings.
In 2010, Dr. Pal founded the Inherited Cancer Registry (ICARE), an initiative which is among the largest research registries focused on inherited cancers in the country. Through these efforts, Dr. Pal has partnered with providers across the United States and beyond to grow the registry and conduct translational studies while providing opportunities for education and engagement for patients and providers.
Tuya Pal, MD
- Vanderbilt University, Professor of Medicine
- Vice Chair, NCCN Genetics/Familial Guidelines Committee for Breast, Ovarian, Pancreatic, and Prostate Cancers
- Editor-in-Chief, National Cancer Institute’s Cancer Genetics PDQ Editorial Board
- Founder, Inherited Cancer Registry (ICARE)
Dr. Pal is a Professor of Medicine at the Vanderbilt University Medical Center, where she is also an Ingram Professor of Cancer Research.
A board-certified practicing clinical cancer geneticist, Dr. Pal’s clinical activities are solely focused on evaluation and management of patients with or at risk for inherited cancer. She is also the Vice Chair of the National Comprehensive Cancer Network Genetics/Familial Guidelines Committee for Breast, Ovarian, Pancreatic, and Prostate Cancers, as well as the Editor-in-Chief for the National Cancer Institute’s Cancer Genetics PDQ Editorial Board.
Dr. Pal’s research has focused on genomics, etiology, outcomes, and care delivery among inherited cancer and/or underrepresented populations, particularly young Black women with breast cancer. She has led multiple efforts focused on alternative models to streamline and scale up care delivery of cancer genetics services across diverse populations and healthcare settings.
In 2010, Dr. Pal founded the Inherited Cancer Registry (ICARE), an initiative which is among the largest research registries focused on inherited cancers in the country. Through these efforts, Dr. Pal has partnered with providers across the United States and beyond to grow the registry and conduct translational studies while providing opportunities for education and engagement for patients and providers.